reference/7097163

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7097163

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	360
issn	0140-6736
issueIdentifier	9330
pageRange	355-360
publicationName	Lancet (London, England)
startingPage	355
bibliographicCitation	Moliterno DJ, Yakubov SJ, DiBattiste PM, Herrmann HC, Stone GW, Macaya C, Neumann FJ, Ardissino D, Bassand JP, Borzi L, Yeung AC, Harris KA, Demopoulos LA, Topol EJ; TARGET investigators. Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study. Lancet. 2002 Aug 03;360(9330):355–60. doi: 10.1016/s0140-6736(02)09605-8. PMID: 12241774.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_21fef99a279e58fa84dbe4a869b0e60c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f43a28cddb5361c38809142fa83c1687 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7a15b0e1a868151f0752f418a40a6e6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7af5dfaace3175ad99ea71f3e7b96475 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff4ddeb21bb3876f99b957369c1fe69e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_041f48a32d2767ba8ce945a1cae0d517 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f9503cd9201a2429a7e920e3470e269 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e6fb1cca35d175f799b186df689cc69 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8f37563e7193f216c6bf6087a994df55 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3da336ff8eb30f879d127ebc7b3d691d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3a9862513491ef51bfbe923afceaaa1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b3a3c0d9d5d37739e102ab1280b2e96d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1bbfa9140ee53c00f04c05ee5ee89e55 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_622900d8d653ccfd44378abcf746ec09
date	2002-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/12241774 https://doi.org/10.1016/s0140-6736%2802%2909605-8
isPartOf	https://portal.issn.org/resource/ISSN/0140-6736 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5470
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study
discusses	http://id.nlm.nih.gov/mesh/M0017012 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0011126 http://id.nlm.nih.gov/mesh/M0211213 http://id.nlm.nih.gov/mesh/M0227707 http://id.nlm.nih.gov/mesh/M0022203 http://id.nlm.nih.gov/mesh/M0028424
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D007140Q000627 http://id.nlm.nih.gov/mesh/D014443Q000627 http://id.nlm.nih.gov/mesh/D014443Q000031 http://id.nlm.nih.gov/mesh/D009203Q000188 http://id.nlm.nih.gov/mesh/D010975Q000627 http://id.nlm.nih.gov/mesh/D015607 http://id.nlm.nih.gov/mesh/D019039Q000037 http://id.nlm.nih.gov/mesh/D000911Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D016032 http://id.nlm.nih.gov/mesh/D000077466 http://id.nlm.nih.gov/mesh/D000077284 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D023381 http://id.nlm.nih.gov/mesh/D009204 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D009203Q000517 http://id.nlm.nih.gov/mesh/D009203Q000401 http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a73b4feef7226074b49b42d83fadea5b http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7334 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8198 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60947 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_77f2a7aa26c2bfc427c7b9e127e4fda9

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243214637 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127654660 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459

Total number of triples: 67.